Literature DB >> 6104489

Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia).

D J Takemoto, R Kresie, D Vaughn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6104489     DOI： 10.1016/s0006-291x(80)80225-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  4 in total

1.  Cyclic GMP phosphodiesterase from bovine retina. Evidence for interspecies conservation.

Authors:  L J Takemoto; J Hansen; D B Farber; D Souza; D J Takemoto
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

Review 2.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

3.  Epidemiologic survey on lung cancer with respect to cigarette smoking and plant diet.

Authors:  R Sakai
Journal:  Jpn J Cancer Res       Date:  1989-06

4.  Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain.

Authors:  Mohankrishna Ghanta; Elango Panchanathan; Bhaskar Venkata Kameswara Subrahmanya Lakkakula; Anbumani Narayanaswamy; P A Abhinand; Stalin Antony
Journal:  Bioinformation       Date:  2018-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.